CONTROVERSIES IN THE MANAGEMENT OF EARLY-STAGE HODGKINS-DISEASE

被引:55
作者
MAUCH, PM
机构
关键词
D O I
10.1182/blood.V83.2.318.bloodjournal832318
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:318 / 329
页数:12
相关论文
共 151 条
[1]   2ND MALIGNANCIES AFTER TREATMENT OF HODGKINS-DISEASE - THE INFLUENCE OF TREATMENT, FOLLOW-UP TIME, AND AGE [J].
ABRAHAMSEN, JF ;
ANDERSEN, A ;
HANNISDAL, E ;
NOME, O ;
ABRAHAMSEN, AF ;
KVALOY, S ;
HOST, H .
JOURNAL OF CLINICAL ONCOLOGY, 1993, 11 (02) :255-261
[2]   A RANDOMIZED STUDY OF ADJUVANT MVPP CHEMOTHERAPY AFTER MANTLE RADIOTHERAPY IN PATHOLOGICALLY STAGED IA-IIB HODGKINS-DISEASE - 10-YEAR FOLLOW-UP [J].
ANDERSON, H ;
CROWTHER, D ;
DEAKIN, DP ;
RYDER, WDJ ;
RADFORD, JA .
ANNALS OF ONCOLOGY, 1991, 2 :49-54
[3]   CHEMOTHERAPY-RADIOTHERAPY SEQUENCE IN THE MANAGEMENT OF HODGKINS-DISEASE - RESULTS OF A CLINICAL-TRIAL [J].
ANDRIEU, JM ;
BAYLEWEISGERBER, C ;
BOIRON, M ;
BRIERE, JF ;
CLOT, P ;
DANA, M ;
JACQUILLAT, C ;
KATZ, M ;
TEILLET, F .
EUROPEAN JOURNAL OF CANCER, 1979, 15 (02) :153-161
[4]   INCREASED RISK OF SECONDARY ACUTE NONLYMPHOCYTIC LEUKEMIA AFTER EXTENDED-FIELD RADIATION-THERAPY COMBINED WITH MOPP CHEMOTHERAPY FOR HODGKINS-DISEASE [J].
ANDRIEU, JM ;
IFRAH, N ;
PAYEN, C ;
FERMANIAN, J ;
COSCAS, Y ;
FLANDRIN, G .
JOURNAL OF CLINICAL ONCOLOGY, 1990, 8 (07) :1148-1154
[5]   2ND LYMPHOID MALIGNANT NEOPLASMS OCCURRING IN PATIENTS TREATED FOR HODGKINS-DISEASE [J].
ARMITAGE, JO ;
DICK, FR ;
GOEKEN, JA ;
FOUCAR, MK ;
GINGRICH, RD .
ARCHIVES OF INTERNAL MEDICINE, 1983, 143 (03) :445-450
[6]   EXTENDED-FIELD RADIOTHERAPY IS SUPERIOR TO MOPP CHEMOTHERAPY FOR THE TREATMENT OF PATHOLOGICAL STAGE-I-IIA HODGKINS-DISEASE - 8-YEAR UPDATE OF AN ITALIAN PROSPECTIVE RANDOMIZED STUDY [J].
BITI, GP ;
CIMINO, G ;
CARTONI, C ;
MAGRINI, SM ;
ANSELMO, AP ;
ENRICI, RM ;
BELLESI, GP ;
BOSI, A ;
PAPA, G ;
GIANNARELLI, D ;
PONTICELLI, P ;
PAPI, MG ;
FERRINI, PLR ;
BIAGINI, C ;
MANDELLI, F .
JOURNAL OF CLINICAL ONCOLOGY, 1992, 10 (03) :378-382
[7]  
BLOKHINA NG, 1985, VESTN AKAD MED NAUK+, P45
[8]  
BLOOMFIELD CD, 1982, CANCER TREAT REP, V66, P835
[9]  
BOIVIN JF, 1992, CANCER, V69, P1241
[10]  
BOIVIN JF, 1984, JNCI-J NATL CANCER I, V72, P233